448 related articles for article (PubMed ID: 23859232)
41. Characterization of the human cysteinyl leukotriene CysLT1 receptor.
Lynch KR; O'Neill GP; Liu Q; Im DS; Sawyer N; Metters KM; Coulombe N; Abramovitz M; Figueroa DJ; Zeng Z; Connolly BM; Bai C; Austin CP; Chateauneuf A; Stocco R; Greig GM; Kargman S; Hooks SB; Hosfield E; Williams DL; Ford-Hutchinson AW; Caskey CT; Evans JF
Nature; 1999 Jun; 399(6738):789-93. PubMed ID: 10391245
[TBL] [Abstract][Full Text] [Related]
42. Functional characteristics of cysteinyl-leukotriene receptor subtypes.
Bäck M
Life Sci; 2002 Jun; 71(6):611-22. PubMed ID: 12072150
[TBL] [Abstract][Full Text] [Related]
43. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
44. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
[TBL] [Abstract][Full Text] [Related]
45. The role of leukotrienes in allergic rhinitis.
Peters-Golden M; Henderson WR
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):609-18; quiz 618-20, 669. PubMed ID: 15984591
[TBL] [Abstract][Full Text] [Related]
46. A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.
Rahman SO; Singh RK; Hussain S; Akhtar M; Najmi AK
Eur J Pharmacol; 2019 Jan; 842():208-220. PubMed ID: 30389631
[TBL] [Abstract][Full Text] [Related]
47. [Substances affecting the synthesis and activity of leukotrienes].
Opletalová V; Hartl J; Bĕhounková M
Ceska Slov Farm; 1997 Apr; 46(2):51-7. PubMed ID: 9244564
[TBL] [Abstract][Full Text] [Related]
48. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
[TBL] [Abstract][Full Text] [Related]
49. P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia.
Ballerini P; Di Iorio P; Ciccarelli R; Caciagli F; Poli A; Beraudi A; Buccella S; D'Alimonte I; D'Auro M; Nargi E; Patricelli P; Visini D; Traversa U
Int J Immunopathol Pharmacol; 2005; 18(2):255-68. PubMed ID: 15888248
[TBL] [Abstract][Full Text] [Related]
50. [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)].
Kohno S; Nabe T
Nihon Rinsho; 2001 Oct; 59(10):1906-12. PubMed ID: 11676130
[TBL] [Abstract][Full Text] [Related]
51. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
52. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature.
Kar M; Altıntoprak N; Muluk NB; Ulusoy S; Bafaqeeh SA; Cingi C
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4111-4117. PubMed ID: 26980339
[TBL] [Abstract][Full Text] [Related]
53. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma.
Parameswaran K; Liang H; Fanat A; Watson R; Snider DP; O'Byrne PM
J Allergy Clin Immunol; 2004 Jul; 114(1):73-9. PubMed ID: 15241347
[TBL] [Abstract][Full Text] [Related]
54. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
[TBL] [Abstract][Full Text] [Related]
55. Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes.
Amrani Y; Moore PE; Hoffman R; Shore SA; Panettieri RA
Am J Respir Crit Care Med; 2001 Dec; 164(11):2098-101. PubMed ID: 11739141
[TBL] [Abstract][Full Text] [Related]
56. Characterization of cysteinyl leukotriene receptors on human saphenous veins: antagonist activity of montelukast and its metabolites.
Mechiche H; Candenas L; Pinto FM; Nazeyrollas P; Clément C; Devillier P
J Cardiovasc Pharmacol; 2004 Jan; 43(1):113-20. PubMed ID: 14668576
[TBL] [Abstract][Full Text] [Related]
57. A dual CysLT
Gauvreau GM; Boulet LP; FitzGerald JM; Cockcroft DW; Davis BE; Leigh R; Tanaka M; Fourre JA; Tanaka M; Nabata T; O'Byrne PM
Allergy; 2016 Dec; 71(12):1721-1727. PubMed ID: 27444660
[TBL] [Abstract][Full Text] [Related]
58. Eosinophils and cysteinyl leukotrienes.
Bandeira-Melo C; Weller PF
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):135-43. PubMed ID: 12895596
[TBL] [Abstract][Full Text] [Related]
59. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
[TBL] [Abstract][Full Text] [Related]
60. A Dual Role for Cysteinyl Leukotriene Receptors in the Pathogenesis of Corneal Infection.
Carion TW; Wang Y; Stambersky A; Ebrahim AS; Berger EA
J Immunol; 2022 May; 208(10):2331-2342. PubMed ID: 35470258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
